Kortekaas J - Search Results

1

Parenteral vaccination of mammalian livestock with Newcastle disease virus-based vector vaccines offers optimal efficacy and safety.

Harmsen MM, Antonis AF, Moormann RJ, Kortekaas J. Harmsen MM, et al. Among authors: kortekaas j. Bioeng Bugs. 2011 Jan-Feb;2(1):58-62. doi: 10.4161/bbug.2.1.13349. Bioeng Bugs. 2011. PMID: 21636990 Free article.

2

Infection of wild-caught wood mice (Apodemus sylvaticus) and yellow-necked mice (A. flavicollis) with tick-borne encephalitis virus.

Bakker JW, Pascoe EL, van de Water S, van Keulen L, de Vries A, Woudstra LC, Esser HJ, Pijlman GP, de Boer WF, Sprong H, Kortekaas J, Wichgers Schreur PJ, Koenraadt CJM. Bakker JW, et al. Among authors: kortekaas j. Sci Rep. 2023 Dec 7;13(1):21627. doi: 10.1038/s41598-023-47697-2. Sci Rep. 2023. PMID: 38062065 Free PMC article.

3

Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.

de Boer SM, Kortekaas J, Antonis AF, Kant J, van Oploo JL, Rottier PJ, Moormann RJ, Bosch BJ. de Boer SM, et al. Among authors: kortekaas j. Vaccine. 2010 Mar 8;28(11):2330-9. doi: 10.1016/j.vaccine.2009.12.062. Epub 2010 Jan 5. Vaccine. 2010. PMID: 20056185

4

Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus.

Kortekaas J, Dekker A, de Boer SM, Weerdmeester K, Vloet RP, de Wit AA, Peeters BP, Moormann RJ. Kortekaas J, et al. Vaccine. 2010 Mar 8;28(11):2271-6. doi: 10.1016/j.vaccine.2010.01.001. Epub 2010 Jan 14. Vaccine. 2010. PMID: 20079874

5

Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.

Kortekaas J, de Boer SM, Kant J, Vloet RP, Antonis AF, Moormann RJ. Kortekaas J, et al. Vaccine. 2010 Jun 17;28(27):4394-401. doi: 10.1016/j.vaccine.2010.04.048. Epub 2010 Apr 29. Vaccine. 2010. PMID: 20434545

6

Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals.

Kortekaas J, Ketelaar J, Vloet RP, Loeffen WL. Kortekaas J, et al. Vet Microbiol. 2011 Jan 10;147(1-2):11-8. doi: 10.1016/j.vetmic.2010.05.038. Epub 2010 Jun 1. Vet Microbiol. 2011. PMID: 20541334

7

Interventions against West Nile virus, Rift Valley fever virus, and Crimean-Congo hemorrhagic fever virus: where are we?

Kortekaas J, Ergönül O, Moormann RJ. Kortekaas J, et al. Vector Borne Zoonotic Dis. 2010 Oct;10(7):709-18. doi: 10.1089/vbz.2010.0040. Vector Borne Zoonotic Dis. 2010. PMID: 20854026

8

Rift Valley Fever Vaccine Development, Progress and Constraints.

Kortekaas J, Zingeser J, de Leeuw P, de La Rocque S, Unger H, Moormann RJ. Kortekaas J, et al. Emerg Infect Dis. 2011 Sep;17(9):e1. doi: 10.3201/eid1709.110506. Emerg Infect Dis. 2011. PMID: 21888781 Free PMC article. No abstract available.

9

Creation of a nonspreading Rift Valley fever virus.

Kortekaas J, Oreshkova N, Cobos-Jiménez V, Vloet RP, Potgieter CA, Moormann RJ. Kortekaas J, et al. J Virol. 2011 Dec;85(23):12622-30. doi: 10.1128/JVI.00841-11. Epub 2011 Sep 28. J Virol. 2011. PMID: 21957302 Free PMC article.

10

Efficacy of three candidate Rift Valley fever vaccines in sheep.

Kortekaas J, Antonis AF, Kant J, Vloet RP, Vogel A, Oreshkova N, de Boer SM, Bosch BJ, Moormann RJ. Kortekaas J, et al. Vaccine. 2012 May 14;30(23):3423-9. doi: 10.1016/j.vaccine.2012.03.027. Epub 2012 Mar 24. Vaccine. 2012. PMID: 22449427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters